Serum 25-hydroxyvitamin D levels in patients with atopic eczema and the influence of narrow-band ultraviolet B phototherapy
Photodermatology, Photoimmunology & Photomedicine. doi: 10.1111/phpp.12117
R F Rose MRCP*, C Williams MRCP, T Oliphant MRCP, F Browne MRCP, D Turner, V Goulden FRCP, MD
Narrow-band ultraviolet B phototherapy (nbUVB) is an established treatment modality for patients with severe atopic dermatitis (AD) and is known to increase serum vitamin D levels (SVD). The relationship between SVD and AD remains unclear.
To assess SVD and disease severity in patients with AD before and after nbUVB and establish whether a change in SVD correlates to response to nbUVB.
A single-centre, open observational study recruited 21 male and 17 female patients with AD between November and April. Eczema severity was measured using the SCORAD tool and serum 25-hydroxyvitamin D3 levels were determined pre- and post- nbUVB which was administered thrice weekly.
9 patients had severe AD, 23 moderate and 6 mild indicated by SCORAD measurements. 17 patients completed the study. Median SVD increased from 45nmol/L pre-treatment to 169nmol/L post treatment (95% CI, 2.9 - 5.0 times baseline) (p<0.0001). Mean SCORAD reduction following nbUVB was significant at 21.9 units (95% CI, 14.9 - 28.9) (p<0.0001). No evidence of a relationship between change in SCORAD and change in SVD was found.
The number of patients failing to complete study.
Patients with AD are at risk of vitamin D deficiency. Correlation between this and disease severity has been postulated but this study does not provide confirmatory evidence.
Patients can buy the PDF from publisher at low cost
Summary by VitaminDWiki
Levels raised from 18 ng to 68 ng
Study duration = 6 months.
No indication of how long the people had useful vitamin D levels (> 40 ng)
only 45% of the people completed the study - no indication if the dropouts were or were not cured